Evolution of renal function after partial and full mechanical support for chronic heart failure

International Journal of Artificial Organs

Volumn 37, Issue 5, 2014, Pages 364-370

  Jacobs, Steven ^a   Droogne, Walter ^a   Waelbers, Valerie ^a   Van den Bossche, Klaartje ^a   Bollen, Hilde ^a   Geens, Jef ^a   Rega, Filip ^a   Burkhoff, Daniel ^b,c   Meyns, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CircuLite Inc   (United States)

Author keywords

LVAD; Partial support; Renal function

Indexed keywords

CARDIOLOGY; HEART;

CHRONIC HEART FAILURES; CLASS I; CONTINUOUS-FLOW; HEART FAILURE; KIDNEY FUNCTION; MECHANICAL SUPPORT; MINIMAL INVASIVE; PARTIAL SUPPORT; RENAL FUNCTIONS; RETROSPECTIVE ANALYSIS;

LEFT VENTRICULAR ASSIST DEVICES;

BUMETANIDE; CREATININE; FUROSEMIDE; DIURETIC AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; BODY MASS; BODY SURFACE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; HEART ASSIST DEVICE; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

ADULT; AGED; BUMETANIDE; CREATININE; DIURETICS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84903120829     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000326     Document Type: Article

References (26)

1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30-41.
2. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008;168(4):418-424.
3. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failurerelated hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52(6):428-434.
4. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD; Resource Utilization Among Congestive Heart Failure (REACH) Study. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39(1):60-69.
5. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25(18):1614-1619.
6. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397-1402.
7. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002;85(1):51-66.
8. Ezekowitz J, McAlister FA, Humphries KH, et al; APPROACH Investigators. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44(8):1587-1592.
9. Lang CC, Mancini DM. Non-cardiac comorbidities in chronic heart failure. Heart. 2007;93(6):665-671.
10. Hillege HL, Nitsch D, Pfeffer MA, et al; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671-678.
11. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115-123.
12. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9): 885-896.
13. Rose EA, Gelijns AC, Moskowitz AJ, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-1443.
14. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28(4):352-359.
15. Letsou GV, Myers TJ, Gregoric ID, et al. Continuous axialflow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003;76(4):1167-1170.
16. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant. 2008;27(5):469-473.
17. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous-or pulsatileflow assist devices. J Heart Lung Transplant. 2007;26(8): 815-818.
18. Meyns BP, Simon A, Klotz S, et al. Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients. Eur J Cardiothorac Surg. 2011;39(5):693-698.
19. Tsukamoto Y. [Principles and methodology of K/DOQI clinical guidelines]. Clin Calcium. 2004;14(5):689-692.
20. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-2100.
21. Slaughter MS, Rogers JG, Milano CA, et al; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241-2251.
22. Hasin T, Topilsky Y, Schirger JA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012;59(1):26-36.
23. Meyns B, Klotz S, Simon A, et al. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol. 2009; 54(1):79-86.
24. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19): 1527-1539.
25. Liu PP. Cardiorenal syndrome in heart failure: a cardiologist's perspective. Can J Cardiol 2008;24(Suppl B):25B-29B.
26. Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008;51(13):1268-1274.